Akero Therapeutics Inc buy Cantor Fitzgerald
Start price
11.10.23
/
50%
€13.80
Target price
11.10.24
€36.75
Performance (%)
86.38%
Price
04.10.24
€25.72
This prediction will end soon
Summary
This prediction is currently active. With a performance of 86.38% the BUY prediction by Cantor_Fitzgerald is a big success. This prediction currently runs until 11.10.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akero Therapeutics Inc | 1.660% | 1.660% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target lowered by analysts at Cantor Fitzgerald from $69.00 to $39.00. They now have an "overweight" rating on the stock.
Ratings data for AKRO provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€20.34
20.06.24
20.06.24
-
20.06.25
20.06.25
26.45%
04.10.24
04.10.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
04.10.23
04.10.23
€65.81
04.10.24
04.10.24
-42.11%
02:15
02:15
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€48.20
19.09.23
19.09.23
€64.47
19.09.24
19.09.24
-48.36%
20.09.24
20.09.24